Please login to order a test.
Carisoprodol/Meprobamate, Screen and Confirmation, Urine
Immunoassay 1 (with reflex to confirmation at an additional charge)
This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA).
Initial testing by immunoassay (IA); confirmation of positives by mass spectrometry (MS)
Maintain specimen at room temperature. If arrival at lab will extend beyond seven days, refrigerate.
This assay is intended for pain management. It is not intended for workplace testing and does not comply with state regulatory workplace testing programs.